Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats

Circulation

Volumn 96, Issue 2, 1997, Pages 689-697

  Mitani, Yoshihide ^a   Maruyama, Kazuo ^a   Sakurai, Minoru ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Endothelium derived factors; Hypertension; Hypoxia; Physiology; Pulmonary; Pulmonary heart disease

Indexed keywords

ARGININE; MONOCROTALINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPOBARISM; LUNG ARTERY PRESSURE; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0030840893     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.2.689     Document Type: Article

References (51)

1. Meyrick B, Reid L. Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. Lab Invest. 1980; 42:603-615.
2. Rosenberg H, Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988;255:H1484-H1491.
3. Adnot S, Raffestin B, Eddahibi S, Braquest P, Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest. 1991;87: 155-162.
4. Maruyama J, Maruyama K. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am J Physiol. 1994;266:H2476-H2488.
5. Altiere RJ, Olson JW, Gillespie MN. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. J Pharmacol Exp Ther. 1986;236:390-395.
6. Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG, Trusler GA, Rowe RD, Olley PM, Cutz E. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. Lab Invest. 1986;55:632-653.
7. Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
8. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med. 1991; 324:1539-1547.
9. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 1993;87:440-446.
10. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet. 1992;388: 1173-1174.
11. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide, a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1992;83:2038-2047.
12. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest. 1994;94:578-584.
13. Roberts JD, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res. 1995;76:215-222.
14. Mehta S, Stewart DJ, Langleben D, Levy RD. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation. 1995;92:1539-1545.
15. Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res. 1989;64:814-825.
16. Maruyama K, Ye C, Woo M, Venkatacharya H, Lines LD, Silver MM, Rabinovitch M. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol. 1991;261: H1716-H1726.
17. Rabinovitch M, Konstam MA, Gamble WJ, Papanicolaou N, Aronovitz MJ, Treves S, Reid L. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ Res. 1983; 52:432-441.
18. Meyrick B, Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation: an ultrastructural study. Lab Invest. 1978; 38:188-200.
19. Hislop A, Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol. 1976;57: 542-554.
20. Grover RF, Johnson RL, McCullough RG, McCullough RE, Hofmeister SE, Campbell WB, Reynolds RC. Pulmonary hypertension and pulmonary vascular reactivity in beagles at high altitude. J Appl Physiol. 1988;65:2632-2640.
21. Wagenvoort CA, Wagenvoort N. Hypoxic pulmonary vascular lesions in man at high altitude and in patients with chronic respiratory disease. Pathol Microbiol (Basel). 1973;39:276-282.
22. Eddahibi S, Adnot S, Carville C, Blouquit Y, Raffestin B. L-Arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol. 1992;263: L194-L200.
23. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
24. Hamon M, Vallet B, Bauter C, Wernert N, McFadden EP, Lablanche J, Dupuis B, Bertrand ME. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 1994;90:1357-1362.
25. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
26. Gallego MJ, Farre AL, Riesco A, Monton M, Granders SM, Barat A, Hernando L, Casado S, Caramelo CA. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: effect of L-arginine . Am J Physiol. 1993;264:H708-H714.
27. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun. 1989;164:714-721.
28. Gold ME, Wood KS, Buga GM, Byrns RE, Ignarro LJ. L-Arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. Biochem Biophys Res Commun. 1989;161:536-543.
29. Palmer RM, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988;153:1252-1256.
30. Zhau L, Crawley DE, Hughes JM, Evans TW, Winter RJ. Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. J Appl Physiol. 1993;74:1061-1065.
31. Hampl V, Archer SL, Nelson DP, Weir EK. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol. 1993;75:1748-1757.
32. Dinh-Xuan AT, Pepke-Zaba J, Higenbottam TW. Impairment of nitric oxide production in isolated pulmonary arteries of patients with chronic hypoxic pulmonary hypertension: putative mechanisms and pathophysiological implications. In: Moncada S, Marietta MA, Higgs JB Jr, Higgs EA, eds. The Biology of Nitric Oxide: 1. Physiological and Clinical Aspects. London, UK: Portland Press; 1992: 381-384.
33. Carville C, Eddahibi S, Adnot S, Raffestin B. In vivo but not in vitro administration of L-arginine restores EDRF activity in pulmonary arteries from chronically hypoxic rats. FASEB J. 1992;6:A1168. Abstract.
34. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993;92:99-104.
35. Eddahibi S, Raffestin B, Clozel M, Levame M, Adnot S. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol. 1995;268: H828-H835.
36. Katayose D, Ohe M, Yamauchi K, Ogata M, Shirato K, Fujita H, Shibahara S, Takishima T. Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am J Physiol. 1993;264:L100-L106.
37. Maruyama J, Maruyama K, Mitani Y, Kitabatake M, Yamauchi T, Miyasaka K. Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats. Am J Physiol. 1997;272:H517-H524.
38. Ono S, Voelkel NF. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J Appl Physiol. 1991;71:2483-2492.
39. Carillo L, Aviado DM. MCT-induced pulmonary hypertension and p-chlorophenylalanine. Lab Invest. 1969;20:243-248.
40. Voelkel NF, Tuder RM, Bridge J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol. 1994;11:664-675.
41. Mcyrick B, Gamble W, Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol. 1980;239:H692-H702.
42. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol. 1995;26:1054-1061.
43. Caterina RD, Libby P, Peng H, Thannickak VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
44. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994;89:2176-2182.
45. Clancy R, Leszczynska-Piziak J, Abramson S. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 1992;90:1116-1121.
46. Huie RE, Padmaja S. Reaction of NO with Superoxide. Free Radic Res Commun. 1993;18:195-199.
47. Carp H, Janoff A. In vivo suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J Clin Invest. 1979;63:793-797.
48. Lo YYC, Cruz TF. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem. 1995;270:11727-11730.
49. Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;90:2056-2069.
50. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20: 452-457.
51. Shimokawa H, Lam JYT, Chesebro JH, Bowie EJW, Vanhoutte PM. Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation. 1987;76:898-905.